Dec 04, 2018 - Acadia has performed well during recent speculative biotech washout.The company's recently announced secondary stock offering threatened to drop the stock back to match its struggling peers.The recent
Nov 08, 2018 - The following slide deck was published by ACADIA Pharmaceuticals Inc. in conjunction with their 2018 Q3 earnings call.
Nov 07, 2018 - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2018 Results Earnings Conference Call November 06, 2018 05:00 PM ET Executives Elena Ridloff - SVP, IR and Interim CFO Steve Davis - President and CEO Mich
Nov 06, 2018 - Acadia (ACAD) delivered earnings and revenue surprises of 13.79% and 0.70%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Oct 19, 2018 - The biotech stocks plunge along with the broader market, as the smallcap and midcap biotech stocks retreat -17%.The larger cap biotechs and pharma are performing relatively much better.The performance
Sep 27, 2018 - Acadia is pretty much a one-therapy company under development for a variety of critical applications.The one FDA-approved indication for Acadia's key therapy, NUPLAZID (pimavanserin), has been under s
Sep 26, 2018 - Data read-outs by quite a few companies grabbed headlines in the biotech sector this week.
Aug 23, 2018 - Dropbox has a great business model.Amgen is cheap compared to Acadia Pharmaceuticals.XPO Logistics is a buy.
Aug 11, 2018 - Possible future competitor to Minerva, Acadia reported decreasing growth visibility and uptake for their drug, Nuplazid.This is likely attributed to recent and relevant safety concerns raised surround
Aug 08, 2018 - The
S&P 500 finished Wednesday slightly lower, ending its four-session winning
streak with an uneven